Inflation Rate Expected to Reach 6 in Second Quarter According to Top Forecasters BP Removes Chair Albert Manifold Amid Governance Concerns Appoints Ian Tyler as Interim Leader Ebola Outbreak Forces DR Congo World Cup Squad to Isolate Ahead of US Entry Potential Economic Ripples Japan Shipbuilding Town Turns to Foreign Workers and AI to Address Labor Crunch US Stock Futures and Bond Yields Dip on Reports of Putins Nuclear Doctrine Update Genpact CEO Says AI Could Reduce IT Workload and Jobs Requiring Higher Skill Sets HWKN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain PRH Q1 2026 Earnings Prudential Financial Beats Estimates by 154 but Security Edges Lower VLTO Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance Acorn Energy Inc ACFN Q4 2025 Earnings Profitability Despite Limited Disclosures GTES Q1 2026 Earnings EPS Beat with 47 Surprise Amid Steady Demand GETY Q1 2026 Earnings EPS Misses Estimates Significantly Stock Declines 345 uniQure QURE Slides 127 as Biotech Sector Faces Headwinds SR Bancorp SRBK Surges Over 2 as Bulls Test Key Resistance at 1964 ImmuCell ICCC Slips Amidst Market Pressure Key Support Levels in Focus Cerus Corporation CERS Consolidates Near 273 as Support and Resistance Levels Hold ASA Gold and Precious Metals ASA Surges 548 as Gold Prices Rally Key Levels to Watch Indian IT Stocks Valuations Attractive After Steep YTD Decline But Analysts Warn Upside May Be Capped Apollo Global Management APO Q1 2026 Earnings EPS Misses by 05 Amid Mixed Market Signals Isabella Bank Corporation ISBA Declines 194 as Sector Headwinds Weigh on Regional Bank Stocks FB Financial FBK Modestly Advances as Stock Holds Above Key Support Hershey HSY Hovers Near Support as Confectionary Giant Faces Modest Pullback Stag Industrial STAG Edges Higher A Modest Gain Amid Defined Trading Range NexMetals Mining Corp NEXM Edges Higher at 281 Testing Key Resistance Levels Sangoma Technologies SANG Edges Higher Testing Key Resistance After 278 Gain ADAMH Senior Notes Edge Lower Income Focus Amid Narrow Trading Range Spero Therapeutics SPRO Hovers Near Support Amid Modest Decline Key Levels in Focus